BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Bone cancer AND BIRC3, AIP1, 330, ENSG00000023445, HIAP1, Q13489, MIHC, CIAP2, API2, cIAP2, MALT2, hiap-1, RNF49, HAIP1 AND Prognosis
24 results:

  • 1. The outcome of patients with Hodgkin lymphoma and early relapse after autologous stem cell transplant has improved in recent years.
    Bazarbachi A; Boumendil A; Finel H; Khvedelidze I; Romejko-Jarosinska J; Tanase A; Akhtar S; Ben Othman T; Ma'koseh M; Afanasyev B; Cheikh J; Briones J; Gülbas Z; Hamladji RM; Elverdi T; Blaise D; Martínez C; Alma E; Halaburda K; Sousa AB; Glass B; Robinson S; Montoto S; Sureda A
    Leukemia; 2022 Jun; 36(6):1646-1653. PubMed ID: 35414657
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. CircRNA_0078767 promotes osteosarcoma progression by increasing CDK14 expression through sponging microRNA-330-3p.
    Zhang G; Zhu Y; Jin C; Shi Q; An X; Song L; Gao F; Li S
    Chem Biol Interact; 2022 Jun; 360():109903. PubMed ID: 35307379
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Pulmonary metastasectomy in bone and soft tissue sarcoma with metastasis to the lung.
    Gusho CA; Seder CW; Lopez-Hisijos N; Blank AT; Batus M
    Interact Cardiovasc Thorac Surg; 2021 Nov; 33(6):879-884. PubMed ID: 34516633
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. The 'other' bone sarcomas in Japan: a retrospective study of primary bone sarcomas other than osteosarcoma, Ewing sarcoma and chondrosarcoma, using data from the bone Tumuor Registry in Japan.
    Nagano A; Tsugita M; Nishimoto Y; Akiyama H; Kawai A
    Jpn J Clin Oncol; 2021 Aug; 51(9):1430-1436. PubMed ID: 34105731
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. bone Metastases, Skeletal-Related Events, and Survival in Patients With Metastatic Non-Small Cell Lung cancer Treated With Immune Checkpoint Inhibitors.
    Qin A; Zhao S; Miah A; Wei L; Patel S; Johns A; Grogan M; Bertino EM; He K; Shields PG; Kalemkerian GP; Gadgeel SM; Ramnath N; Schneider BJ; Hassan KA; Szerlip N; Chopra Z; Journey S; Waninger J; Spakowicz D; Carbone DP; Presley CJ; Otterson GA; Green MD; Owen DH
    J Natl Compr Canc Netw; 2021 Apr; 19(8):915-921. PubMed ID: 33878726
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. ciap2 expression and clinical significance in pigmented villonodular synovitis.
    Ding Z; Bai Z; Zhang M; Sun B; He Y
    J Mol Histol; 2021 Apr; 52(2):397-406. PubMed ID: 33599891
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Does Adding Femoral Lengthening at the Time of Rotation Hip Transposition After Periacetabular Tumor Resection Allow for Restoration of Limb Length and Function? Interim Results of a Modified Hip Transposition Procedure.
    Xu H; Li Y; Zhang Q; Hao L; Yu F; Niu X
    Clin Orthop Relat Res; 2021 Jul; 479(7):1521-1530. PubMed ID: 33534263
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Prognostic value of epidermal growth factor receptor gene mutation in resected lung adenocarcinoma.
    Deng C; Zhang Y; Ma Z; Fu F; Deng L; Li Y; Chen H
    J Thorac Cardiovasc Surg; 2021 Sep; 162(3):664-674.e7. PubMed ID: 32747123
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Is Skeletal Imaging Essential in the Staging Workup for Conventional Chondrosarcoma?
    Gulia A; Kurisunkal V; Puri A; Purandare N; Gupta S; Rangarajan Drm V
    Clin Orthop Relat Res; 2020 Nov; 478(11):2480-2484. PubMed ID: 32567825
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Role of miRNA-542-5p in the tumorigenesis of osteosarcoma.
    Zhu T; Fan D; Ye K; Liu B; Cui Z; Liu Z; Tian Y
    FEBS Open Bio; 2020 Apr; 10(4):627-636. PubMed ID: 32105410
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. MicroRNA-330-5p promotes the development of osteosarcoma by regulating SPRY2.
    Wei Q; Li QQ; Zhai XC; Qin L; Li HB; Meng R; Han XF
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8761-8770. PubMed ID: 31696462
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Pain REduction with bone metastases STereotactic radiotherapy (PREST): A phase III randomized multicentric trial.
    Cellini F; Manfrida S; Deodato F; Cilla S; Maranzano E; Pergolizzi S; Arcidiacono F; Di Franco R; Pastore F; Muto M; Borzillo V; Donati CM; Siepe G; Parisi S; Salatino A; D'Agostino A; Montesi G; Santacaterina A; Fusco V; Santarelli M; Gambacorta MA; Corvò R; Morganti AG; Masiello V; Muto P; Valentini V
    Trials; 2019 Oct; 20(1):609. PubMed ID: 31661034
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort.
    Smeland S; Bielack SS; Whelan J; Bernstein M; Hogendoorn P; Krailo MD; Gorlick R; Janeway KA; Ingleby FC; Anninga J; Antal I; Arndt C; Brown KLB; Butterfass-Bahloul T; Calaminus G; Capra M; Dhooge C; Eriksson M; Flanagan AM; Friedel G; Gebhardt MC; Gelderblom H; Goldsby R; Grier HE; Grimer R; Hawkins DS; Hecker-Nolting S; Sundby Hall K; Isakoff MS; Jovic G; Kühne T; Kager L; von Kalle T; Kabickova E; Lang S; Lau CC; Leavey PJ; Lessnick SL; Mascarenhas L; Mayer-Steinacker R; Meyers PA; Nagarajan R; Randall RL; Reichardt P; Renard M; Rechnitzer C; Schwartz CL; Strauss S; Teot L; Timmermann B; Sydes MR; Marina N
    Eur J Cancer; 2019 Mar; 109():36-50. PubMed ID: 30685685
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. The prognostic value of multiorgan metastases in patients with non-small cell lung cancer and its variants: a SEER-based study.
    Yang J; Zhang Y; Sun X; Gusdon AM; Song N; Chen L; Jiang G; Huang Y
    J Cancer Res Clin Oncol; 2018 Sep; 144(9):1835-1842. PubMed ID: 30003315
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Immune cell contexture in the bone marrow tumor microenvironment impacts therapy response in CML.
    Brück O; Blom S; Dufva O; Turkki R; Chheda H; Ribeiro A; Kovanen P; Aittokallio T; Koskenvesa P; Kallioniemi O; Porkka K; Pellinen T; Mustjoki S
    Leukemia; 2018 Jul; 32(7):1643-1656. PubMed ID: 29925907
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. MicroRNA-330-3p Expression Indicates Good prognosis and Suppresses Cell Proliferation by Targeting Bmi-1 in Osteosarcoma.
    Zheng Z; Bao F; Chen X; Huang H; Zhang X
    Cell Physiol Biochem; 2018; 46(2):442-450. PubMed ID: 29614499
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. KPT-330, a potent and selective exportin-1 (XPO-1) inhibitor, shows antitumor effects modulating the expression of cyclin D1 and survivin [corrected] in prostate cancer models.
    Gravina GL; Mancini A; Sanita P; Vitale F; Marampon F; Ventura L; Landesman Y; McCauley D; Kauffman M; Shacham S; Festuccia C
    BMC Cancer; 2015 Dec; 15():941. PubMed ID: 26620414
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Development and validation of prognostic nomograms for metastatic gastrointestinal stromal tumour treated with imatinib.
    Lee CK; Goldstein D; Gibbs E; Joensuu H; Zalcberg J; Verweij J; Casali PG; Maki RG; Cioffi A; Mcarthur G; Lord SJ; Yip D; Kanjanapan Y; Rutkowski P
    Eur J Cancer; 2015 May; 51(7):852-60. PubMed ID: 25801699
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Bcl-2 expression is associated with poor prognosis of solitary plasmacytoma of bone.
    Guo S; Zhi Y; Yang H; Yu Y; Wang Y; Zhang J; Wang G; Zhang L; Sun B; Zhang Y
    Ann Hematol; 2014 Mar; 93(3):471-7. PubMed ID: 24013520
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. PTEN genomic deletions that characterize aggressive prostate cancer originate close to segmental duplications.
    Yoshimoto M; Ludkovski O; DeGrace D; Williams JL; Evans A; Sircar K; Bismar TA; Nuin P; Squire JA
    Genes Chromosomes Cancer; 2012 Feb; 51(2):149-60. PubMed ID: 22045666
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.